ScholarWorks@Korea University College of Medicine: Lee, Moon Soo

Detailed Information

Lee, Moon Soo (이문수)

Guro Hospital (Department of Psychiatry, Guro Hospital)

Research Area: 우울장애, 조울병, 틱장애, depressive disorder, bipolar disorder, Tourette disorder

Tel 02-2626-3163
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Depression:20||Adolescent:11||Schizophrenia:8||depression:7||Suicide:6||COVID19:5||Adherence:5||bipolar disorder:4||Bipolar disorder:4||schizophrenia:4||Quality of life:4||Major depressive disorder:4||Anxiety:3||prolactin:3||Type D personality:3||Adolescents:3||항우울제:3||adolescents:3||Guideline:3||methylphenidate:3||Medication Event Monitoring System:3||Antidepressant:3||조현병:3||Medicationnaive:3||Attentiondeficit hyperactivity disorder:3||Heart rate variability:3||diagnosis:3||aripiprazole:3||Inflammation:3||Insight:3||Posttraumatic stress disorder:3||진료지침:2||Physical activity:2||Referral and Consultation Psychiatry:2||machine learning:2||Amygdala:2||menstruation:2||mental illness:2||계절성:2||informed consent:2||Moderator:2||consent competency to treatment:2||Assessment:2||neuroimaging:2||Women:2||panic disorder:2||Obesity:2||Workers:2||depressive disorder:2||Primary Health Care:2||KYRBS:2||Stress:2||efficacy:2||역학:2||adolescent:2||우울증:2||fMRI:2||Epidemiology:2||amygdala:2||Chronic Disease:2||Cytokines:2||Switching:2||restingstate functional connectivity:2||자살:2||Firstepisode:2||risperidone:2||DS14:2||biomarker:2||ROC analysis:2||testosterone:2||Firstonset:1||Firstonset.:1||Functional MRI:1||Functional impairment:1||Functional level:1||G protein:1||GingerALE:1||Global Standards:1||Health Insurance Review and Assessment Service Data:1||Health risk behaviors:1||Healthcare workers:1||Heart rave variability:1||Highsensitivity Creactive protein:1||Hippocampus:1||Hospitalized medical patient:1||Hypertension:1||IDEARiSCo:1||IESRK:1||Initial choice:1||Injections:1||Insula:1||Internalizing problem:1||Internet Addiction:1||Internet addiction disorder:1||Internet addiction· Temperament· Character· Interpersonal relations.:1||Internet use time:1||Interpersonal Relations:1||KACAP:1||Korea:1||Korea National Health and Nutrition Examination Survey:1||Korean.:1||Lifestyle factors:1||Machine learning:1||Mania:1||Medication event monitoring system:1||Medication satisfaction questionnaire:1||Menopausal Symptoms:1||Menopausal symptoms·Attitude toward menopause·Menopause·Depression·Anxiety.:1||Metaanalysis:1||Metabolic syndrome:1||Microstructure:1||Minor stress·Coping·Quality of life·Hemodialysis.:1||Mirtazapine.:1||Negative symptom:1||Neuroimmunology:1||Neuroinflammation:1||North Korean defector:1||Omega3:1||PANSS:1||PHQ9:1||PSS:1||Pain:1||Paliperidone ER:1||Parenting stress index.:1||Parents:1||Pathological worry:1||Personal and social functioning:1||Pharmacological Treatment:1||Pharmacological treatment:1||Pharmacotherapy:1||Placebo:1||Plasminogen activator inhibitor 1:1||Polymorphism:1||Polyunsaturated Fatty Acids:1||Postmenopausal Women:1||Postmenopause:1||Postmenopause·Depressive disorder·Hormone replacement treatment·Estrogens.:1||Practice parameter.:1||Predicting factor:1||Pregnancy:1||Premenopause:1||Premenstrual dysphoric disorder:1||Premenstrual syndrome:1||Prevalence:1||Prospective design:1||Prospective studies:1||Psychiatric consultation:1||Psychiatry:1||Psychopathology:1||Psychopharmacology:1||Psychosocial intervention:1||Psychotropic drugs:1||Public sector:1||Quetiapine · Risperidone · Prolactin· 무월경· Estradiol.:1||Quetiapine· Risperidone· Prolactin· · Estradiol.:1||ROC:1||Referral:1||Reliability:1||Resilience:1||Resting state functional connectivity:1||Reward:1||SPAQ:1||SWNK:1||Schizophrenia· ECT· Child.:1||Schizophrenia· Korean medication algorithm· Feasibility· Therapeutic environment.:1||School dropout:1||School mental health:1||Seedtovoxel:1||Shortterm measurement:1||Sleep assessment·Sleep log·Actigraphy.:1||Sleep quality:1||Smartphone:1||Smartphone addiction:1||Social support:1||Student dropout:1||Subjective wellbeing:1||Substance Abuse:1||Suicidal ideation:1||Suicide Risk:1||Symptom:1||Symptoms:1||TCI:1||Temperament:1||Testosterone· Sexual function· Depresion.:1||Tic:1||Tic disorder:1||Tourette disorder:1||Tourette syndrome:1||Tourette's disorder:1||Transcranical magnetic stimulation·Tourette syndrome·Motor evoked potential.:1||Traumatic Stress:1||Treatment:1||Treatment compliance.:1||Triglyceride:1||Tryptophan hydroxylase 2:1||Type D Personality:1||Type D personality(DS14)·Cardiovascular disease·Coronary artery disease.:1||TypeD personality:1||Validity.:1||Valproate:1||Weight:1||Weight gain:1||Work hours:1||Workfamily conflict:1||Workplace gender discrimination:1||Worry scale:1||Ziprasidone:1||Zonisamide:1||adolescence:1||adverse effect:1||amenorrhea:1||antidepressant induced mania:1||antipsychotics:1||anxiety:1||anxiety disorder:1||assessment:1||attention deficit disorder with hyperactivity:1||attentiondeficit hyperactivity disorder:1||attentiondeficit/hyperactivity disorder:1||attitudes:1||atypical antipsychotics:1||autonomic nervous system:1||biomarkers:1||brainderived neurotrophic factor:1||bromocriptine:1||bupropion:1||child:1||chronicity:1||circadian rhythm:1||classification:1||clinician rating scale:1||cognitive behavior therapy:1||cognitive function:1||combination treatment:1||comorbidities:1||comorbidity:1||coronary heart disease:1||cortical thickness:1||costeffectiveness:1||cytokines:1||data collection:1||default mode network:1||dehydroepiandrosterone sulfate:1||development:1||dorsolateral prefrontal cortex:1||drugnaive:1||duration of illness:1||education:1||erectile dysfunction:1||executive function:1||firstepisode schizophrenia:1||firstonset:1||followup:1||free testosterone:1||frontoparietal network:1||gene polymorphisms:1||haloperidol:1||heart rate variability:1||high risk:1||hormone replacement therapy:1||hyperprolactinemia:1||hypothalamicpituitarygonadal axis:1||interoceptive exposure:1||kiddieschedule for affective disorder and schizophreniaparent and lifetime versionKorean version:1||knowledge:1||learning:1||lithium:1||longacting injection risperidone:1||longacting injections:1||longitudinal:1||maintenance:1||major depression:1||major depressive disorder:1||major depressive disorders:1||medication event monitoring system:1||medication use:1||menopause:1||mental health:1||metaanalysis:1||mindfulnessbased intervention:1||mirtazapine:1||mobile health:1||mood disorder:1||needs:1||negative symptoms:1||obesity:1||parental stress:1||partner:1||pediatric:1||pediatric bipolar disorder:1||perceived functioning:1||pharmacological treatment:1||pharmacotherapy:1||physiological responses:1||pill count:1||polymorphism:1||practices:1||prediction:1||premenstrual syndrome:1||psychopathology:1||psychological:1||quality of life:1||questionnaire:1||quetiapine:1||randomized controlled trial:1||recurrence:1||relapse:1||relaxation:1||relaxation therapy:1||research domain criteria (RDoC):1||retrospective cohort study:1||selfreport:1||sexual dysfunction:1||sociocultural aspect:1||stress:1||suicidal ideation:1||support vector machine:1||symptom severity:1||tardive dyskinesia:1||tolerability:1||treatment compliance:1||treatment response:1||valproic acid:1||virtual reality:1||waist circumference:1||weight loss:1||wellbeing:1||zonisamide:1||강화요법:1||개인적 사회적 기능상태:1||걱정 척도·병적인 걱정·신뢰도·타당도.:1||경두개 자기자극술·뚜렛 증후군·틱.:1||경두개 자기지극술:1||계절성 정동장애:1||고지된 동의:1||공공영역 종사자:1||교체:1||기능수준:1||기저질환:1||동의:1||뚜렛 증후군:1||말초성 피로·중추성 피로·유산소 운동능력·세로토닌·카테콜라민.:1||병식:1||병합요법:1||사회적 지지:1||소아·청소년·독소·위험인자·우울증·유전자·환경.:1||소아기 우울장애:1||수면평가·수면일지·활동기록기.:1||순응도:1||스마트폰·정신과·아동·청소년:1||약물 순응도·알츠하이머 병·치매:1||약물만족도:1||약물치료:1||약물학적 치료:1||여성:1||여학:1||예측 인자:1||우울장애:1||우울증상:1||월경전기증후군:1||월경전불쾌장애:1||위약:1||유병률:1||응급실:1||의뢰:1||인격:1||인지 기능.:1||인터넷 중독·기질성격 특성·청소년·대인관계.:1||입원 환자:1||자문조정정신의학·소아청소년·정신사회적 모델·생의학적 모델.:1||적정시점.:1||정신건강의학과:1||정신과 자문·치료순응도.:1||정신병리:1||정신분열병·전기경련요법·소아.:1||정신분열병·한국형 약물치료 알고리듬·임상 적용 연구·치료환경.:1||정신장애인:1||주요우울장애:1||주의력결핍 과잉행동장애 ·메칠페니데이트 ·신경생물학 ·신경약물학:1||주의력결핍 과잉행동장애·심박 변이도·노력 할당·부모의 양육 스트레스 척도.:1||증량:1||직무 스트레스:1||청소년·확산텐서영상·우울장애·구조적 연결성·초발.:1||초기선택:1||치료동의능력:1||코로나바이러스:1||태도:1||테스토스테론·성기능·우울증.:1||통증:1||틱:1||폐경에 대한 태도·폐경기 증상·폐경·우울·불안.:1||폐경전기·폐경후기·우울증·Mirtazapine.:1||폐경후기·우울증·호르몬 대치요법·에스
트로겐.:1||폐경후기·폐경기 증상·위험요인·삶의 질.:1||한국청소년:1||한국형.:1||혈액투석·Minor stressor·대처방식·삶의 질.:1||효과 차이:1||07045917:1||효과판정:1||ADHD:1||Addictive Behavior:1||Adipokine:1||Adolescence:1||Affect:1||Age Differences:1||Alcohol drinking:1||Alzheimer’s disease:1||Anger:1||Antenatal depression:1||Anticonvulsants:1||Antipsychotic agents:1||Appropriate time:1||Attention deficit hyperactivity disorder:1||AttentionDeficit/Hyperactivity Disorder:1||Attitude:1||Augmentation.:1||Autonomic instability:1||Autonomic nervous system:1||BDNF:1||Behavioral rating scale:1||Bone density:1||Bone metabolism:1||Brief resilience scale:1||Cardiovascular disease:1||Cell phones · Psychiatry · Child · Adolescent:1||Central fatigue·Peripheral fatigue·Aerobic capacity·Serotonin·Catecholamine.:1||Child:1||Childhood Depressive Disorder:1||Children:1||Children and adolescents:1||Child·Adolescent·Toxin·Risk Factor·Depressive Disorder·Gene·Environment.:1||Chronic medical condition:1||Clinical guidelines:1||Code of Medical Ethics:1||Cognitive function:1||Combination:1||Comorbidity:1||Compliance:1||Conn:1||Consultationliaison psychiatry·Child·Psychosocial model·Biomedical model.:1||Coronary Disease:1||Cytokine:1||DS14:1||Decision making:1||Delayedaction preparations:1||Dementia:1||Depressive disorder:1||Depressive mood:1||Depressive symptom:1||Diagnosis:1||Difference in efficacy:1||Diffusion tensor imaging:1||Drug adherence:1||Drug monitoring:1||Drugnaïve:1||Dyadic Relationship:1||D형 인격·DS14·심혈관 질환·관상동맥질환:1||Efficacy judgment.:1||Effort allocation:1||Emergency:1||Emotion:1||Emotional regulation:1||Emotional support:1||Employees:1||Employees.:1||Expressed emotion:1||Family climate:1||Females:1||

STATISTICS: Total View :12,650,631; Today View :4,509

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE